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Accepted 5 November 2018; Published online 13 November 2018AbstractObjectives: To establish current practice of the management of learning and clustering effects, by treating center and surgeon, in the
design and analysis of randomized surgical trials.
Study Design and Setting: The need for more surgical randomized trials is well recognized, and in recent years conduct has grown.
Rigorous design, conduct, and analyses of such studies is important. Two methodological challenges are clustering effects, by center or
surgeon, and surgical learning on trial outcomes. Sixteen leading journals were searched for randomized trials published within a two-year
period. Data were extracted on considerations for learning and clustering effects.
Results: A total of 247 eligible studies were identified. Trials accounted for learning with 2% using an expertise-based design and 39%
accounting for expertise by predefining surgeon credentials. One study analyzed learning. Clustering, by site and surgeon, was commonly
managed by stratifying randomization, although one-third of center and 40% of surgeon stratified trials did not also adjust analysis.
Conclusion: Considerations for surgical learning and clustering effects are often unclear. Methods are varied and demonstrate poor
adherence to established reporting guidelines. It is recommended that researchers consider these issues on a trial-by-trial basis, and report
methods or justify where not needed to inform interpretation of results.  2018 The Authors. Published by Elsevier Inc. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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The need for more surgical randomized trials is well
recognized [1], and in recent years, the number of surgical
trials has grown [2]. Further growth is expected with lead-
ing research organizations setting out to improve the evi-
dence base on a global scale [3e7]. Ensuring that these
trials are designed, conducted, and analyzed with the high-
est possible rigor will support clinical decision-making.
Interacting components in surgical interventions, such as the
procedure itself, surgeon expertise, and aftercare, increase the
complexity in assessing these interventions [8]. The existence
and impact of surgical learning curves, where a surgeon’s* Corresponding author. Medicines for Children Clinical Trials Unit,
Clinical Trials Research Centre, University of Liverpool, Institute of Child
Health, Alder Hey Children’s NHS Foundation Trust, Liverpool L12 2AP,
UK. Tel.: þ44-151-795-8791; Fax: þ44-151-795-8770.
E-mail address: ejconroy@liverpool.ac.uk (E.J. Conroy).
https://doi.org/10.1016/j.jclinepi.2018.11.004
0895-4356/ 2018 The Authors. Published by Elsevier Inc. This is an open acc
licenses/by-nc-nd/4.0/).expertise increases throughout the course of a trial, should be
considered. This may be particularly relevant when a trial is
evaluating new interventions. Another important consideration
is clustering, where variation in outcomes may be smaller be-
tween patients treated by the same surgeon or center than pa-
tients treated by different surgeons or centers. It is
recommended that these issues are considered in multicenter
clinical trials [9] andmayhave increased relevancewithin some
surgical trials dependent on the interventions under investiga-
tion and their levels of routine use [8e12]. Recognizing and
managing these components appropriately can therefore be a
challenge when designing and analyzing such trials.
Communicating these considerations through complete
and transparent reporting can aid appraisal and interpreta-
tion by the wider surgical community. Reporting standards
for trials of nonpharmacologic treatments, such as surgery,
have been established [13,14]. Among their requirements,
reporting of items specifically relating to learning curves
and clustering are recommended [13,14].ess article under the CC BY-NC-ND license (http://creativecommons.org/
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Key findings
 A novel assessment of the management of surgical
learning and clustering is presented.
 A lack of consideration for surgical learning and
clustering is identified.
What this adds to what was known?
 This review represents practice across a wide vari-
ety of trials, both by surgical discipline and by
geographic location, published within a cohort of
leading surgical and medical journals.
 This review is timely as represents publications at a
time of remarkable growth within the surgical field.
What is the implication and what should change
now?
 When considerations are made, methods are varied
and demonstrate poor adherence to established re-
porting guidelines.
 Recommendations are provided about when and
how to address surgical learning and clustering in
the design, conduct and analysis of randomised
surgical trials.
Learning curves and clustering have so far been investi-
gated in isolation, often within specific fields and including
studies of observational design [15,16]. The objective of
this work was to provide an up-to-date and comprehensive
overview of current practice in randomized surgical trials
with regards to the management of surgical learning and
clustering effects in design and analysis.2. Materials and methods
2.1. Included studies
This work sought to review reports of randomized surgi-
cal trials within the wider surgical literature. Articles for in-
clusion in the cohort were identified by undertaking an
electronic search using SCOPUS from a subset of journals.
These journals were identified as the ten leading English-
language general surgical journals (1e10, Box A1) [17] plus
six general medical journals (11e16, Box A1). The rationale
for selecting leading surgical and general medical journals
was the assumption of endorsing high standards of reporting
when publishing randomized controlled trials (RCTs). Pri-
mary reports of the results of RCTs evaluating a surgical
intervention or a nonsurgical intervention, which required
surgery to be administered, published from January 1,
2014, to the date the search was conducted (February 11,2016), were eligible. Duplicate publications, secondary ana-
lyses, and interim reports of RCTs were excluded. All RCTs
meeting these criteria were included in this cohort.
2.2. Data extraction
Selected journals were screened for RCTs that meet the
eligibility criteria. Supplement A1 lists the search strategy
for SCOPUS. E.J.C. screened articles to identify those
eligible for selection. Because of the nature of the interven-
tion of interest, full texts were screened to determine eligi-
bility. When suitability was unclear, a second reviewer
(C.G.) was consulted.
A data extraction form was developed by two authors
(E.J.C. and C.G.), revised based on feedback from G.B.,
J.A.C., and J.M.B., and subsequently piloted on 30 articles
before roll out to all articles (see Supplement A2). Data
were extracted from all articles by a single assessor
E.J.C. Data extracted were quality checked through double
data extraction by a second reviewer (A.R.H.) on 10% of
the articles. An error rate was specified a priori such that
if greater than 5% across all fields, then a further 10%
would be checked until the error rate was below 5%. Data
were extracted from all published materials (main trial
report and, where applicable, supplementary material).
Data were extracted on generic trial design, for example,
randomization details and statistical analyses related to clus-
tering and learning at a center and surgeon level. Predetermined
center and/or surgeon credentials and variables relating to sur-
gical learning or clustering, either as a definitive outcome or as
a variable of interest, such as duration of operation or the num-
ber of operations by surgical level were collected.
2.3. Statistical analysis
Quantitative items were summarized using descriptive
statistics; no formal statistical comparisons were under-
taken. SAS 9.3 (SAS Institute Inc., Cary, NC, USA) was
used. Open textual responses were categorized using NVivo
qualitative data analysis software (QSR International Pty
Ltd. Version 10, 2012).
3. Results
3.1. Article details
The search identified 874 reports (398 in 2014; 446 in
2015; and 30 in 2016 to date of extraction February 11,
2016), of which 247 were eligible. Figure A1 provides
the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses flow diagram. Supplement A3 and Table A1
provide a list of eligible studies and summarize the cohort
demographics respectively. Two surgical specialty journals
and three general medical journals contributed most of the
eligible articles (Table A1). When reported (n 5 167/247,
68%), more than half of eligible trials were European
funded (n 5 92/167, 54%), and more than one-fourth were
North American funded (n 5 48/167, 29%).
Table 1. Trial design features and characteristics
Item Category n N n/N (%)
Trial type Definitive study 240 247 97
External pilot or feasibility [18] 7 247 3
Type Cluster 3 247 1
Cross-overa 2 247 1
Factorial 6 247 2
Parallel 231 247 94
Sequential 5 247 2
Number of arms 2 224 247 91
3 16 247 6
4 6 247 2
6 1 247 !1
Some trial personnel blinded Yes 157 247 64
No 47 247 19
Not reported 43 247 17
Expertise design Puredprofessionals delivering only
one interventionb
4 247 2
Hybriddsome professionals could deliver
bothc
1 247 !1
Intervention of interest Surgery occurred but was not intervention
of interest
105 247 43
Surgery occurred and was the intervention
of interest
142 247 57
Comparator when surgery was
intervention of interestd
Surgery 111 142 78
Medical 10 142 7
Other, such as active monitoring 25 142 18
Surgical comparison in trials
comparing two surgeries
Comparing different components of the
same intervention
68 111 61
Different surgical interventions 38 111 34
Different time points of the same
intervention
5 111 5
a Includes designs in which each participant receives both interventions.
b Reason for design: trial exploring effects of different training techniques for surgeons (n 5 1); surgeon equipoise and belief of potential
impact of learning curve (n 5 1); trial exploring delivery differences between two types of health professionals (n 5 1); not provided (n 5 1).
c Reason for design: surgical preference (n 5 1).
d Four studies classified twice as three arm and, therefore, two comparators.
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eligible articles for double data extraction. Of 1,025 vari-
ables checked, 12 errors were identified (1.2%).
3.2. Trial rationale and design
Design features and characteristics of the trials are sum-
marized in Table 1. Included trials were typically of a par-
allel (n 5 231, 94%), two-armed (n 5 224, 91%) design.
Sixty-four percent described approaches to blinding trial
personnel (n 5 157, 64%).
Within the cohort, more than half of the trials were re-
ported as multicenter (n 5 130, 53%) and two-thirds were
reported as multiple surgeons/care providers (n 5 162,
66%; Table 2).Very few trials used an expertise-based design [19],
where the health professionals deliver only one of the com-
parators (n 5 5, 2%). One of these used a hybrid design
where some health professionals could deliver both inter-
ventions. Care providers/surgeons were allocated to arm
based on preference (n 5 2, of which one was a hybrid),
randomization (n 5 2), and the research question (n 5 1;
Table 1).
3.3. Intervention of interest
Surgery occurred and was the intervention under evalu-
ation in approximately 60% of trials (n 5 142; Table 1).
Three-quarters (n 5 111, 78%) of these also had a surgical
comparator. The majority of which compared different
Table 2. Randomization considerations
Item Category n N n/N (%)
Multiple or single center trial Multiple 130 247 53
Single 101 247 41
Not reported 16 247 6
Multiple or single care provider trial Multiple 162 247 66
Single 22 247 9
Not reported 63 247 25
Randomization stratified Yes 123 247 50
No 124 247 50
If yes, randomization stratified by Center and care provider 2 123 2
Center 77 123 63
Care provider 8 123 6
Neither 36 123 29
Allocation of care provider Puredprofessionals delivering only one intervention
Defined by research question 1 4 25
Preference 1 4 25
Randomized 2 4 50
Hybriddsome professionals could deliver both
Preference 1 1 100
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one-third compared different surgical interventions
(n 5 38/111, 34%), and a small number compared different
time points of the same intervention, such as early or de-
layed surgery (n 5 5/111, 5%). Box A2 gives an example
from each category where surgery was a comparator. In tri-
als where the intervention under evaluation was not surgery,
surgery was a cointervention (n 5 105, 43%; Table 1), for
example, a trial of neoadjuvant chemotherapy and surgery
where surgery was the same in both arms.Table 3. Center and surgeon credentials
Item Category
Credentials defined No, or not reported
Yes
If credentials defined, at what level Both center and surgeon
Center only
Surgeon only
Center credentials Experience required witho
Prior number of cases defi
Piloted technique
Study-specific training
Surgeon credentials Experience required witho
Prior number of cases
Level or job role
Study-specific training
Oversight or supervision
Local practice followed
Experience in years
Quality control by video3.4. Center and surgeon credentials
Predefined center and surgeon credentials were reported
in 41% of trials (n 5 101; Table 3). This included 95 of the
162 multi surgeon trials, with common definitions being a
set prior number of cases (n 5 27) or a specific level or
job role, for example consultant (n 5 22). Fourteen trials
reported criteria at center level, of which nine reported
these alongside surgeon criteria. Examples of reported
criteria are summarized in Table 3.n N n/N (%)
146 247 59
101 247 41
9 101 9
5 101 5
87 101 87
ut definition 8 14 57
ned 5 14 36
1 14 7
1 14 7
ut definition 29 96 30
27 96 28
22 96 23
21 96 22
17 96 18
10 96 10
3 96 3
2 96 2
Table 4. Adjustment and stratification by comparator in multi surgeon trials
Comparator of interest
Stratified by surgeon Analysis adjusts for surgeon
Yes No Yes No
N n n/N (%) n n/N (%) n n/N (%) n n/N (%)
Totals 162 10 6 152 94 20 12 152 88
Surgery occurred but not intervention
of interest
66 2 3 64 97 4 6 62 94
Surgery vs. medical 8 0 0 8 100 1 12 7 88
Surgery vs. other 20 0 0 20 100 1 5 19 95
Surgery vs. surgery
Different components of the same
intervention
45 3 7 42 94 7 16 38 84
Different surgical interventions 23 5 22 18 78 8 35 15 65
Different time points of the same
intervention
3 0 0 3 100 0 0 3 100
Three trials counted across two comparator types as three arm studies.
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Table 2 provides a summary of randomization consider-
ations. Half stratified the randomization (n 5 123, 50%),
using methods such as block randomization or minimiza-
tion. Seventy-nine of the 130 multicenter trials stratified
by center (61%), and ten of the 162 multiple surgeon trials
stratified by surgeon (n 5 10/162, 6%). Of the surgeon
stratified trials (n 5 10), half were trials comparing
different components of the same intervention (n 5 5;
Table 4). Two trials stratified by both center and care pro-
vider/surgeon, and almost half stratified by neither
(n 5 75/162, 46%). Table A2 provides further exploration
of the stratification approach within multi surgeon trials.
3.6. Considerations of learning and clustering of
centers and surgeons
Variables reported relating to learning (Box A3) were
background or level of surgeon or center (n 5 14, 5%, of
which one gave both); experience in years (n 5 5, 2%);
number of operations by surgeon level (n 5 13, 5%); or
over time (n 5 1, !1%). Operation time was most
commonly reported (n 5 82, 33%). Variables relating to
clustering (Box A3) were number of patients by regionTable 5. Stratification of randomization by analysis adjustment by center an
Stratification factor N
Total All outcomes P
N (%) n (%)
Center
Yes 79 26 (33) 10 (38)
No 51 6 (12) 2 (33)
Care provider
Yes 10 4 (40) 2 (50)
No 152 12 (8) 4 (33)(n 5 1, !1%); center (n 5 39, 16%); surgeon (n 5 13,
5%); the number of surgeons per center (n 5 1, !1%);
and the overlap of surgeons between arms (n 5 2, 1%).
Of the 79 multicenter trials that stratified by center,
one-third (n 5 25) reported within center descriptive
data, for example caseload. Likewise, of the ten stratified
multicare provider trials, half (n 5 5) reported descrip-
tive data (Table A3).
Outcomes potentially relevant to clustering or learning,
for example length of operation, are presented in Box A4.
Eighty percent (198/247) reported on at least one outcome
relevant to clustering or learning curves, with the most
commonly reported being safety events (n 5 129, 51%)
and infection (n 5 46, 19%).3.7. Analysis adjustment of centers and surgeons
Center or care provider, when used to stratify the random-
ization process, was used to adjust the analysis in one-third of
trials (n5 26/79, 33%, Table 5). Of the ten trials that stratified
by care provider, fourmade analysis adjustments.One-third of
multicenter (n5 45, 35%) and almost 90% of multi care pro-
vider trials (n 5 140, 86%) neither stratified randomization
nor made analysis adjustments.d care provider
Analysis stratified
Yes
Norimary outcome only Secondary outcomes only
n (%) n (%) N (%)
14 (54) 2 (8) 53 (67)
4 (66) 0 (0) 45 (88)
2 (50) 0 (0) 6 (60)
6 (50) 2 (17) 140 (92)
Table 6. Statistical adjustment for multiple center and surgeon effects in primary or secondary analyses
Item Category
Center Surgeon
n N n/N (%) n N n/N (%)
Analyses to address the potential
effect planned
Yes 39 130 30 20 162 12
No, but considered 2 130 2 1 162 1
No 89 130 68 142 162 88
If yes, approach used Term in regression model 32 39 82 15 20 75
Separate exploratory analysis 4 39 10 0 20 0
Other approach 3 39 8 3 20 15
Effect type where term in regression
model
Fixed 1 32 3 2 15 13
Random 16 32 50 6 15 40
Time varying 0 32 0 1 15 7
Unclear 15 32 47 6 15 40
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primary or secondary outcomes (16%; Table 6). When re-
ported, adjustment using a random effect was more com-
mon (n 5 16) than fixed effects (n 5 1). Adjustments
were applied to all outcomes in one-third of trials and to
primary outcome only in almost half. Other approaches
included: a sensitivity analysis excluding the center with
the largest number of participants and center being used
as a predictor to impute missing values.
Twenty trials considered surgeon effect in analysis of
primary or secondary outcomes (8%; Table 6), with two-
fifths of these being trials comparing different surgical in-
terventions (n 5 8, 40%; Table 4). Adjustments were
applied to all outcomes in one-third of trials and to primary
outcome only in 40%. Other approaches were to explore
safety of surgeons in delivering interventions in a separate
paper and to consider ‘‘run in’’ patients where the first 100
patients were randomized separately in analysis.4. Conclusions
This review examines methods for addressing learning
and clustering effects within a large cohort of 247 random-
ized surgical trials. Most commonly, learning effects were
addressed in the design of the trial by surgeon or center
participation requirements, for example, number of previ-
ous operations. Expertise-based studies were rare, although
some may have been expertise based in delivery but not re-
ported as such [20]. One study conducted a formal investi-
gation of the learning curve using a time-varying treatment
effect. Clustering was also most commonly accounted for
in the design stage by stratifying the randomization process
by center and/or surgeon. However, in most cases, the anal-
ysis was not then adjusted to reflect this [21].
Numerous examples in the literature demonstrate the
presence of a learning curve and investigate the impact
on outcomes over time [22,23]. In the surgical field, theappropriateness of making considerations for surgeon in
an individual trial should be considered against how
commonplace and stabilized the procedure or intervention
are within routine practice. For example, consideration
may be given to whether the trial is comparing established
practices, established practices with minor differences, or
entirely different or radical new procedures. Formal anal-
ysis of surgical learning was rare. When triallists consider
the learning curve to be of interest, for example early phase
studies involving radical new procedures, established statis-
tical methods that allow the learning profile to be explored
may be considered [24].
Approaches tomanage clustering at the surgeon level were
less prevalent than at site level within this cohort. This may be
appropriate reflecting on the nature of the interventions being
compared and their routine use. Impact of care bundles, for
example pre- and post-surgical care, may be considered to
exert a greater influence on outcomes than individual surgeon.
These aspects of care are typically center-driven effects.
Furthermore, a large cohort analysis of cardiac patients deter-
mined that 95% of variation in the outcome of interest was ex-
plained by patient risk factors, with surgeon and center
contributing only 2%e3% respectively [25]. This raises the
question of the importance of adjusting for surgeon particu-
larly where the volume of data available limits the extent of
modeling techniques. It is important to note thatwhen surgeon
and/or site are prognostic indicators in a trial, the randomiza-
tion of the trial will often be balanced for this, commonly
through stratifying the randomization process [9,26,27].How-
ever, the subsequent analysis should be adjusted for these cho-
sen stratification factors. Failure to adjust following
stratification can inflate p-values and confidence interval
widths potentially creating erroneous conclusions of no treat-
ment benefit [21]. Within this cohort, one-third of site
stratified trials and 40% of surgeon stratified trials reported
making necessary adjustments to the analysis.
This review has identified potential deficiencies in the
design and analysis of surgical trials. The regulatory
Box 1. Considerations and recommendations for design and analysis
Learning curve considerations and recommendations by scenario
Scenario Recommendations
Interventions delivered by the same specialty and/or surgeons and:
Delivered routinely within clinical practice LC-1
Delivered routinely within clinical practice, with one intervention being a minor modification of the other LC-1, LC-2, LC-4
Radical new procedure being compared with intervention commonly used within routine practice LC-1, LC-2, LC-4, LC-5
Interventions delivered by different specialties and/or surgeons and:
Delivered routinely within clinical practice LC-1, LC-2, LC-3
Radical new procedure being compared with intervention commonly used within routine practice LC-1, LC-2, LC-3, LC-5
Recommendations to mitigate any potential learning effect
LC-1 Consider defining care provider experience required to deliver the interventions.
LC-2 Consider whether trial specified training, at site or surgeon level, is required.
LC-3 Consider the appropriateness of an expertise-based vs. conventional design.
LC-4 Consider monitoring of protocol adherence and treatment delivery
LC-5 Consider whether it is appropriate to explore surgical learning as a secondary analysis of interest.
Clustering considerations and recommendations by scenario
Scenario Recommendations
Randomization has to be performed at center level for logistical, not prognostic, reasons. C-1
Randomization has to be performed at surgeon level for logistical, not prognostic, reasons. C-2
Care bundle (pre- and post-operative care) varies between center. C-1, C-3, C-4, C-5, C-6
Treatment delivery within site, or surgeon, may differ because of routine practice. C-4, C-5, C-6
Center is a known prognostic indicator of outcome, for example because of patient population. C-1, C-3, C-7
Surgeon is considered a prognostic indicator of outcome C-2, C-3, C-7
Recommendations to mitigate
any potential effect
C-1 Consider balancing randomization, as appropriate, with respect to center through stratification or minimization.
C-2 Consider balancing randomization, as appropriate, with respect to surgeon through stratification or
minimization.
C-3 Balancing randomization can introduce correlation in outcomes within strata, analysis should subsequently be
adjusted for prognostic factors on which the randomization is based to avoid potentially inflated p values and
loss of power.
C-4 Consider stricter protocol requirements for treatment delivery.
C-5 Consider increasing monitoring of protocol adherence and treatment delivery.
C-6 Consider treatment effects across centers, these should be explored routinely to appropriately consider the
generalizability of results. Not that treatment differences observed may be because of factors irrelevant of
these. In this case, exploratory analysis into other factors may be warranted.
C-7 Regardless of randomization balancing factors, consider adjusting the analysis for prognostic factors. Note,
interpretation of unadjusted analysis may be impacted.
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ceutical trials, however many of the requirements are
directly relevant [9,26e28]. The ICH E9 Statistical Princi-
ples for Clinical Trials document discusses the variable rea-
sons for conducting multicenter trials and the importance of
defining the center appropriately, either by center or inves-
tigator [9]. This is directly applicable to surgical trials.
Further guidance states that the potential for differential
treatment effects across centers should be explored, with in-
dividual center results being reported and treatment-by-
center interactions considered in the absence ofhomogeneity [9,28]. Our results show that practice does
not follow this guideline, with one-third of multicenter
studies, and 13% of multi surgeon studies, reporting ap-
proaches to check for differential outcome effects or justi-
fying not doing so. It is important to remember that
heterogeneity may be caused by factors not related to the
surgeon. Heterogeneity may be explained at the center
level, for example by differences in patient demographics,
or at the level of the care provider/surgeon, for example
because of variation in case mix complexity. Existence of
heterogeneity between centers has implications for
34 E.J. Conroy et al. / Journal of Clinical Epidemiology 107 (2019) 27e35generalizability of study results and should be routinely
investigated to appropriately consider generalizability.
There is an absence of guidelines focusing on learning
curves, which may be due to them originating specifically
for medicinal trials. Other reasons for lack of guidance
may be due to: expectations that learning curves are not ex-
pected in trials comparing commonly used practices; ex-
pectations that learning is suitably addressed, in training
and selection of care providers, before trial commence-
ment; or due to difficulties in measuring surgeon expertise,
with method often being imperfect and subject to other in-
fluences, such as case mix.
The need for transparency around learning curves and
clustering are highlighted within the guidelines on report-
ing of nonpharmacologic interventions [13,14]. This review
identified poor adherence to these reporting guidelines with
key requirements missing or only partially reported.
Coupled with the poor adherence to good statistical practice
guidelines [9], limitations in reporting may strengthen the
concerns by health professionals that surgical research is
of a poor quality, as this can ultimately lead to ill
founded clinical decisions [13,14].
When interpreting these results, it is important to
consider the limitations of this review. First, this cohort
was restricted to top surgical and medical journals;
although advantageous as it provides a wide variety of trials
by surgical discipline and geographic location, these trials
are more likely of a higher quality and better methodolog-
ical practice because of wider adoption of reporting guide-
lines [29]. Second, this cohort is cross-sectional and,
therefore, does not consider changes over time. However,
because of the recent growth in surgical trials, and the
establishment of reporting guidelines for trials such as sur-
gery, it is likely that little is to be gained from reviewing
more dated literature. Finally, drawing conclusions based
on published articles may be hindered by a lack of trans-
parent reporting. Because of word count constraints and
within journal requirements, authors may not have been
able to fully report methods used despite all available sup-
plementary material being searched during this review.
Further insight into methods used could have been obtained
by interviews with authors although this would be resource
intensive. Further insight into current practice could be
informed by contact with current surgical trialists and stat-
isticians, or by exploring trial documentation that may not
be published, such as grant applications or protocols.
Fundamental to the design and analysis of a trial is the
understanding of the trial objectives. Many multicenter tri-
als are multicenter not because of interests in how treatment
effects vary by center or surgeon but because of logistical
considerations, or to provide a better basis for the subse-
quent generalization of its findings and to ensure sufficient
availability of the patient population. Considerations and
recommendations for design and analysis are presented
for surgical learning and clustering in Box 1, based on cur-
rent guidelines and recommendations through examplescenarios [9,13,14,21,26e28]. These aspects of trial design
and analysis demonstrate the need for early and continued
expert statistical input [16].Acknowledgments
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